Table 3.
Median overall survival in months, stratified by race/ethnicity
| White (n=401) | Black (n=384) | Hispanic (n=332) | Black vs. White (HR, 95%CI) | Hispanic vs. White (HR, 95%CI) | |
|---|---|---|---|---|---|
| Overall | 16.3 (5.2 – 61.2) | 10.6 (3.3 – 34.1) | 14.4 (3.9 – 52.7) | 1.34 (1.12 – 1.60) | 1.08 (0.89 – 1.30) |
| BCLC stage A | 45 (17.0 – 94.6) | 28.4 (13.2 – 55.7) | 42.6 (17.0 – 82.6) | 1.4 (0.97 – 1.91) | 0.93 (0.64 – 1.36) |
| BCLC stage B | 14.8 (6.0 – 29.8) | 16.8 (8.4 –27.8) | 16.0 (7.9 – 22.0) | 0.92 (0.59 – 1.42) | 1.11 (0.72 – 1.72) |
| BCLC stage C | 5.8 (1.8 – 10.3) | 4.5 (2.0 – 7.9) | 4.0 (2.2 – 7.9) | 1.13 (0.83 – 1.55) | 1.07 (0.75 – 1.52) |
| BCLC stage D | 2.3 (1.2 – 13.6) | 1.5 (0.7 – 3.1) | 3.5 (1.1 – 8.5) | 1.77 (1.19 – 2.62) | 0.97 (0.66 – 1.43) |
BCLC – Barcelona Clinic Liver Cancer
Interquartile ranges (IQR) reported for median survival time